🟢 Spero Therapeutics is trading 5.2% up today tracking biotech sector strength

Spero Therapeutics is trading 5.2% up at $1.21 today, tracking broader strength across the biotechnology sector.

• The stock is bouncing back after several sessions of mild downward pressure, moving in tandem with a strong biotech tape.
• There are no fresh company-specific catalysts reported today, including earnings, FDA updates, or analyst commentary.
• The upward move appears driven by sector-wide tailwinds rather than new fundamental developments.